Literature DB >> 2414779

Ion channel block by acetylcholine, carbachol and suberyldicholine at the frog neuromuscular junction.

D C Ogden, D Colquhoun.   

Abstract

Three nicotinic agonists, suberyldicholine, acetylcholine and carbachol, have been investigated by single channel recording at the endplates of adult frog muscle fibres. All three agonists can block the channels that they open. Suberyldicholine is the most potent blocker; it has an equilibrium constant for binding to the open channel of about 6 microM and blockages last for about 5 ms on average, at -105 mV. A plot of the mean number of blockages per unit open time against concentration ('blockage frequency plot') suggests that suberyldicholine does not produce long-lived blocked states such as might occur, for example, if it could be trapped within a shut channel. The characteristics of the 'blockage frequency plot' are analysed in Appendix 2. Block by acetylcholine and carbachol has much lower affinity (the equilibrium constants being a few millimolar for both), and blockages are much briefer, so that blockage appears to produce noisy single channel currents of reduced amplitude. A method based on the spectral density of the excess 'open' channel noise has been used to investigate the rate of blocking and unblocking. The basis of this method is discussed in Appendix 1. It is estimated that the mean duration of a blockage is about 18 microseconds for acetylcholine and 9 microseconds for carbachol.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2414779     DOI: 10.1098/rspb.1985.0065

Source DB:  PubMed          Journal:  Proc R Soc Lond B Biol Sci        ISSN: 0950-1193


  78 in total

1.  Mechanism-based discovery of ligands that counteract inhibition of the nicotinic acetylcholine receptor by cocaine and MK-801.

Authors:  G P Hess; H Ulrich; H G Breitinger; L Niu; A M Gameiro; C Grewer; S Srivastava; J E Ippolito; S M Lee; V Jayaraman; S E Coombs
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

Review 2.  Activation of skeletal muscle nicotinic acetylcholine receptors.

Authors:  C J Lingle; D Maconochie; J H Steinbach
Journal:  J Membr Biol       Date:  1992-03       Impact factor: 1.843

3.  Activation of heteroliganded mouse muscle nicotinic receptors.

Authors:  Gustav Akk; Lorin S Milescu; Manfred Heckmann
Journal:  J Physiol       Date:  2005-02-17       Impact factor: 5.182

4.  Short openings in high resolution single channel recordings of mouse nicotinic receptors.

Authors:  Stefan Hallermann; Sabine Heckmann; Josef Dudel; Manfred Heckmann
Journal:  J Physiol       Date:  2005-01-27       Impact factor: 5.182

5.  Paired motor neuron-muscle recordings in zebrafish test the receptor blockade model for shaping synaptic current.

Authors:  Hua Wen; Paul Brehm
Journal:  J Neurosci       Date:  2005-08-31       Impact factor: 6.167

6.  Desensitization of acetylcholine receptors in BC3H-1 cells.

Authors:  J P Dilger; Y Liu
Journal:  Pflugers Arch       Date:  1992-04       Impact factor: 3.657

7.  Direct measurement of the concentration- and time-dependent open probability of the nicotinic acetylcholine receptor channel.

Authors:  J P Dilger; R S Brett
Journal:  Biophys J       Date:  1990-04       Impact factor: 4.033

8.  The voltage-dependent block of ATP-sensitive potassium channels of frog skeletal muscle by caesium and barium ions.

Authors:  J M Quayle; N B Standen; P R Stanfield
Journal:  J Physiol       Date:  1988-11       Impact factor: 5.182

9.  Effect of chemical modification of extracellular histidyl residues on the channel properties of the nicotinic acetylcholine receptor.

Authors:  C B Bouzat; H D Lacorazza; M Biscoglio de Jiménez Bonino; F J Barrantes
Journal:  Pflugers Arch       Date:  1993-06       Impact factor: 3.657

10.  Activation and cooperative multi-ion block of single nicotinic-acetylcholine channel currents of Ascaris muscle by the tetrahydropyrimidine anthelmintic, morantel.

Authors:  A M Evans; R J Martin
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.